Excessive bleeding from the vad outflow graft was noted during the hvad implant procedure, when the patient was being weaned from cardio-pulmonary bypass (cpb).Bleeding was noted from the outflow graft.Upon inspection, a slit in the outflow graft was seen under the pump strain relief.The site reported no unusual difficulties in attaching the outflow graft and strain relief to the vad outflow cannula and the graft was dry when it was attached.The clamp had required some hand tightening.The vad was stopped and the patient returned to cpb.The strain relief and the outflow graft were removed from the pump and the graft cut to remove the affected portion.The unaffected portion of the outflow graft and the strain relief were re-attached to the pump.The vad was re-started and the patient was successfully weaned from cpb.No further bleeding was seen from the outflow graft.A picture of the outflow graft was taken and it appears that a visible slit is aligned to where the clamp would have been tightened.Investigation is ongoing.
|
The hvad is used for treatment not diagnosis.The site reported that during an lvad implantation it was noted that there was excessive bleeding emanating from the outflow graft.The patient remained under cardio-pulmonary bypass as the surgeon removed the cut/torn section of the graft and reattached the remaining portion of the outflow graft back on to the pump.There was no reported patient injury as a result of this event.The outflow graft was not returned as it remained implanted; however the site did provide the manufacturer with pictures for reference.Evaluation of the pictures received showed a longitudinal tear on the outflow graft proximal to the pump, potentially indicative of an over tightened strain relief clamp.The pictures corroborated the site's account that the strain relief clamp would not close and was therefore potentially over tightened.A possible root cause for the reported event could be as a result of over-tightening the clamp during the lvad implant procedure.The ventricular assist system is indicated for use as a bridge to cardiac transplantation in patients who are at risk of death from refractory end-stage left ventricular heart failure.The system is designed for in-hospital and out-of-hospital settings, including transportation.The instructions for use (ifu) and training material provide clear instructions on the correct outflow graft placement to avoid kinking or rupture.Moreover, the ifu provides instruction to further educate the user about product safety, alarm management, and anticoagulation recommendations; additional guidelines instruct the both the user and medical personnel on how to detect and react to a suspected thrombus formation.Heartware is submitting this report as a result of remediation activities related to fda warning letter fla-14-14, dated june 2, 2014, and pursuant to the provisions of 21 cfr part 803.
|